News | December 07, 2021
RDIF offers vaccine for adolescents aged 12-17 in India
Sputnik M is a new member of the Sputnik vaccines family
Sputnik M is a new member of the Sputnik vaccines family
Data builds on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
The fund aims at investing in companies that extends human healthspan
Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron
It is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively, enabling the detection of more cancer for removal
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Subscribe To Our Newsletter & Stay Updated
